EBITDA Growth
-1772.64%
Quarterly · Period ending:
ZYME EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-1772.64%period ending
Latest reported-1772.64%period ending
ZYME Quarterly EBITDA YoY % (-29.91% → -1772.64%)
Year-over-year change
High-resolution chart · PNG
ZYME ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -1,772.636% | |
| -85.6381% | |
| -114.5715% | |
| 50.3577% | |
| 111.2208% | |
| -6.8086% | |
| 7.41% | |
| -18.1862% | |
| 48.665% | |
| 12.4864% | |
| -106.254% | |
| 44.5077% | |
| 27.9589% | |
| 64.5273% | |
| 917.4061% | |
| 17.2118% | |
| 5.5872% | |
| -59.3529% | |
| -12.9871% | |
| 18.0792% | |
| -73.6504% | |
| -27.9149% | |
| 51.3941% | |
| -122.783% | |
| -40.6403% | |
| -152.6119% | |
| -763.3346% | |
| -81.9578% | |
| -728.6108% | |
| 36.3499% | |
| -68.4513% | |
| -13.2149% | |
| 66.7074% | |
| -36.737% | |
| 443.7229% | |
| -27.4502% | |
| -45.3146% | |
| -58.0204% | |
| -29.9057% |